The habenula couples the dopaminergic and the serotonergic systems: application to depression in Parkinson's disease

A high percentage of patients with Parkinson’s disease suffer from depression in addition to their motor disabilities. However, the etiology of this depression and its relation to Parkinson’s disease are unknown. Within the framework of the monoamine deficiency hypothesis of depression, we propose t...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The European journal of neuroscience 2012-09, Vol.36 (6), p.2822-2829
Hauptverfasser: Sourani, Daphna, Eitan, Renana, Gordon, Noam, Goelman, Gadi
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2829
container_issue 6
container_start_page 2822
container_title The European journal of neuroscience
container_volume 36
creator Sourani, Daphna
Eitan, Renana
Gordon, Noam
Goelman, Gadi
description A high percentage of patients with Parkinson’s disease suffer from depression in addition to their motor disabilities. However, the etiology of this depression and its relation to Parkinson’s disease are unknown. Within the framework of the monoamine deficiency hypothesis of depression, we propose that the dopaminergic and serotonergic systems are coupled by the lateral habenula, and argue that altered basal ganglia activity leads to lateral habenula hyperactivity, which in turn down‐regulates the serotonergic system, resulting in depressive symptoms in patients with Parkinson’s disease. We tested this hypothesis using the unilateral 6‐hydroxydopamine hemiparkinsonian rat model of Parkinson’s disease. Behavior was assessed using the novelty suppressed feeding and forced swim tests, and the effective connectivity of the serotonergic system was estimated by manganese‐enhanced magnetic resonance imaging of the raphe nuclei. The results show depression‐like behaviors and reduced raphe connectivity with the lateral habenula, dentate gyrus of the hippocampus, thalamus and hypothalamus in the 6‐hydroxydopamine rat groups. More importantly, partial restoration of the raphe connectivity and partial normalization of behavior were achieved by dopamine replacement therapy (apomorphine, 10 mg/kg, s.c. daily). Furthermore, nearly complete behavioral normalization was reached after a bilateral electric lesion of the lateral habenula. These findings provide a plausible link between Parkinson’s disease and depression and open up avenues for new therapeutic interventions in depression and possibly in Parkinson’s disease. A high percentage of patients with Parkinson’s disease suffer from depression in addition to their motor disabilities. However, the etiology of this depression and its relation to Parkinson’s disease are unknown.
doi_str_mv 10.1111/j.1460-9568.2012.08200.x
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1093447848</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1041143449</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4900-52e65c7281f11c61ab8733b17ed4b2db877ccc786f011b7ca50c84306b015533</originalsourceid><addsrcrecordid>eNqNkU1v1DAQhi0EokvpX0C-wSXBn7GDxAFVpQWtCq1WasXFchwv9ZLEaSYRu_8ep7vsub7YM37emcODEKYkp-l83ORUFCQrZaFzRijLiWaE5NsXaHH8eIkWpJQ807S4P0FvADaEEF0I-RqdMKaUKAVboHH14PGDrXw3NRa7OPWNBzymZh1724bOD7-Dw7arn5rghzjGQxN2MPoWPmHb901wdgyxw2PEte8HDzBXocM_7fAndBC794DrAN6Cf4terW0D_uxwn6LV14vV-VW2_HH57fzLMnOiJCSTzBfSKabpmlJXUFtpxXlFla9FxepUKeec0sWaUFopZyVxWnBSVIRKyfkp-rAf2w_xcfIwmjaA801jOx8nMJSUXAilhX4GKigViS4TqveoGyLA4NemH0Jrh12CzGzHbMwswcwSzGzHPNkx2xR9d9gyVa2vj8H_OhLweQ_8DY3fPXuwufh-Pb9SPtvnQzKzPeaTAVMorqS5u740N_LXkt3yK3PD_wFCIq3O</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1041143449</pqid></control><display><type>article</type><title>The habenula couples the dopaminergic and the serotonergic systems: application to depression in Parkinson's disease</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Sourani, Daphna ; Eitan, Renana ; Gordon, Noam ; Goelman, Gadi</creator><creatorcontrib>Sourani, Daphna ; Eitan, Renana ; Gordon, Noam ; Goelman, Gadi</creatorcontrib><description>A high percentage of patients with Parkinson’s disease suffer from depression in addition to their motor disabilities. However, the etiology of this depression and its relation to Parkinson’s disease are unknown. Within the framework of the monoamine deficiency hypothesis of depression, we propose that the dopaminergic and serotonergic systems are coupled by the lateral habenula, and argue that altered basal ganglia activity leads to lateral habenula hyperactivity, which in turn down‐regulates the serotonergic system, resulting in depressive symptoms in patients with Parkinson’s disease. We tested this hypothesis using the unilateral 6‐hydroxydopamine hemiparkinsonian rat model of Parkinson’s disease. Behavior was assessed using the novelty suppressed feeding and forced swim tests, and the effective connectivity of the serotonergic system was estimated by manganese‐enhanced magnetic resonance imaging of the raphe nuclei. The results show depression‐like behaviors and reduced raphe connectivity with the lateral habenula, dentate gyrus of the hippocampus, thalamus and hypothalamus in the 6‐hydroxydopamine rat groups. More importantly, partial restoration of the raphe connectivity and partial normalization of behavior were achieved by dopamine replacement therapy (apomorphine, 10 mg/kg, s.c. daily). Furthermore, nearly complete behavioral normalization was reached after a bilateral electric lesion of the lateral habenula. These findings provide a plausible link between Parkinson’s disease and depression and open up avenues for new therapeutic interventions in depression and possibly in Parkinson’s disease. A high percentage of patients with Parkinson’s disease suffer from depression in addition to their motor disabilities. However, the etiology of this depression and its relation to Parkinson’s disease are unknown.</description><identifier>ISSN: 0953-816X</identifier><identifier>EISSN: 1460-9568</identifier><identifier>DOI: 10.1111/j.1460-9568.2012.08200.x</identifier><identifier>PMID: 22774942</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>6-Hydroxydopamine ; 6-hydroxydopamine rat model ; Animal models ; Animals ; Antiparkinson Agents - pharmacology ; Apomorphine - pharmacology ; Basal ganglia ; Dentate gyrus ; Depression ; Depression - etiology ; Dopamine ; Dopamine - physiology ; Etiology ; Habenula ; Habenula - physiopathology ; Hippocampus ; Hippocampus - physiopathology ; lateral habenula ; Magnetic Resonance Imaging ; Male ; manganese-enhanced magnetic resonance imaging ; Movement disorders ; Neural networks ; Neurodegenerative diseases ; Neuropsychological Tests ; Novelty ; Parkinson's disease ; Parkinsonian Disorders - complications ; Parkinsonian Disorders - drug therapy ; Parkinsonian Disorders - physiopathology ; raphe ; Raphe nuclei ; Raphe Nuclei - physiopathology ; Rats ; Rats, Sprague-Dawley ; Serotonin ; Serotonin - physiology ; Swimming ; Thalamus ; Thalamus - physiopathology ; Therapeutic applications</subject><ispartof>The European journal of neuroscience, 2012-09, Vol.36 (6), p.2822-2829</ispartof><rights>2012 The Authors. European Journal of Neuroscience © 2012 Federation of European Neuroscience Societies and Blackwell Publishing Ltd</rights><rights>2012 The Authors. European Journal of Neuroscience © 2012 Federation of European Neuroscience Societies and Blackwell Publishing Ltd.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4900-52e65c7281f11c61ab8733b17ed4b2db877ccc786f011b7ca50c84306b015533</citedby><cites>FETCH-LOGICAL-c4900-52e65c7281f11c61ab8733b17ed4b2db877ccc786f011b7ca50c84306b015533</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1460-9568.2012.08200.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1460-9568.2012.08200.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22774942$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sourani, Daphna</creatorcontrib><creatorcontrib>Eitan, Renana</creatorcontrib><creatorcontrib>Gordon, Noam</creatorcontrib><creatorcontrib>Goelman, Gadi</creatorcontrib><title>The habenula couples the dopaminergic and the serotonergic systems: application to depression in Parkinson's disease</title><title>The European journal of neuroscience</title><addtitle>Eur J Neurosci</addtitle><description>A high percentage of patients with Parkinson’s disease suffer from depression in addition to their motor disabilities. However, the etiology of this depression and its relation to Parkinson’s disease are unknown. Within the framework of the monoamine deficiency hypothesis of depression, we propose that the dopaminergic and serotonergic systems are coupled by the lateral habenula, and argue that altered basal ganglia activity leads to lateral habenula hyperactivity, which in turn down‐regulates the serotonergic system, resulting in depressive symptoms in patients with Parkinson’s disease. We tested this hypothesis using the unilateral 6‐hydroxydopamine hemiparkinsonian rat model of Parkinson’s disease. Behavior was assessed using the novelty suppressed feeding and forced swim tests, and the effective connectivity of the serotonergic system was estimated by manganese‐enhanced magnetic resonance imaging of the raphe nuclei. The results show depression‐like behaviors and reduced raphe connectivity with the lateral habenula, dentate gyrus of the hippocampus, thalamus and hypothalamus in the 6‐hydroxydopamine rat groups. More importantly, partial restoration of the raphe connectivity and partial normalization of behavior were achieved by dopamine replacement therapy (apomorphine, 10 mg/kg, s.c. daily). Furthermore, nearly complete behavioral normalization was reached after a bilateral electric lesion of the lateral habenula. These findings provide a plausible link between Parkinson’s disease and depression and open up avenues for new therapeutic interventions in depression and possibly in Parkinson’s disease. A high percentage of patients with Parkinson’s disease suffer from depression in addition to their motor disabilities. However, the etiology of this depression and its relation to Parkinson’s disease are unknown.</description><subject>6-Hydroxydopamine</subject><subject>6-hydroxydopamine rat model</subject><subject>Animal models</subject><subject>Animals</subject><subject>Antiparkinson Agents - pharmacology</subject><subject>Apomorphine - pharmacology</subject><subject>Basal ganglia</subject><subject>Dentate gyrus</subject><subject>Depression</subject><subject>Depression - etiology</subject><subject>Dopamine</subject><subject>Dopamine - physiology</subject><subject>Etiology</subject><subject>Habenula</subject><subject>Habenula - physiopathology</subject><subject>Hippocampus</subject><subject>Hippocampus - physiopathology</subject><subject>lateral habenula</subject><subject>Magnetic Resonance Imaging</subject><subject>Male</subject><subject>manganese-enhanced magnetic resonance imaging</subject><subject>Movement disorders</subject><subject>Neural networks</subject><subject>Neurodegenerative diseases</subject><subject>Neuropsychological Tests</subject><subject>Novelty</subject><subject>Parkinson's disease</subject><subject>Parkinsonian Disorders - complications</subject><subject>Parkinsonian Disorders - drug therapy</subject><subject>Parkinsonian Disorders - physiopathology</subject><subject>raphe</subject><subject>Raphe nuclei</subject><subject>Raphe Nuclei - physiopathology</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Serotonin</subject><subject>Serotonin - physiology</subject><subject>Swimming</subject><subject>Thalamus</subject><subject>Thalamus - physiopathology</subject><subject>Therapeutic applications</subject><issn>0953-816X</issn><issn>1460-9568</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkU1v1DAQhi0EokvpX0C-wSXBn7GDxAFVpQWtCq1WasXFchwv9ZLEaSYRu_8ep7vsub7YM37emcODEKYkp-l83ORUFCQrZaFzRijLiWaE5NsXaHH8eIkWpJQ807S4P0FvADaEEF0I-RqdMKaUKAVboHH14PGDrXw3NRa7OPWNBzymZh1724bOD7-Dw7arn5rghzjGQxN2MPoWPmHb901wdgyxw2PEte8HDzBXocM_7fAndBC794DrAN6Cf4terW0D_uxwn6LV14vV-VW2_HH57fzLMnOiJCSTzBfSKabpmlJXUFtpxXlFla9FxepUKeec0sWaUFopZyVxWnBSVIRKyfkp-rAf2w_xcfIwmjaA801jOx8nMJSUXAilhX4GKigViS4TqveoGyLA4NemH0Jrh12CzGzHbMwswcwSzGzHPNkx2xR9d9gyVa2vj8H_OhLweQ_8DY3fPXuwufh-Pb9SPtvnQzKzPeaTAVMorqS5u740N_LXkt3yK3PD_wFCIq3O</recordid><startdate>201209</startdate><enddate>201209</enddate><creator>Sourani, Daphna</creator><creator>Eitan, Renana</creator><creator>Gordon, Noam</creator><creator>Goelman, Gadi</creator><general>Blackwell Publishing Ltd</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7TK</scope></search><sort><creationdate>201209</creationdate><title>The habenula couples the dopaminergic and the serotonergic systems: application to depression in Parkinson's disease</title><author>Sourani, Daphna ; Eitan, Renana ; Gordon, Noam ; Goelman, Gadi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4900-52e65c7281f11c61ab8733b17ed4b2db877ccc786f011b7ca50c84306b015533</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>6-Hydroxydopamine</topic><topic>6-hydroxydopamine rat model</topic><topic>Animal models</topic><topic>Animals</topic><topic>Antiparkinson Agents - pharmacology</topic><topic>Apomorphine - pharmacology</topic><topic>Basal ganglia</topic><topic>Dentate gyrus</topic><topic>Depression</topic><topic>Depression - etiology</topic><topic>Dopamine</topic><topic>Dopamine - physiology</topic><topic>Etiology</topic><topic>Habenula</topic><topic>Habenula - physiopathology</topic><topic>Hippocampus</topic><topic>Hippocampus - physiopathology</topic><topic>lateral habenula</topic><topic>Magnetic Resonance Imaging</topic><topic>Male</topic><topic>manganese-enhanced magnetic resonance imaging</topic><topic>Movement disorders</topic><topic>Neural networks</topic><topic>Neurodegenerative diseases</topic><topic>Neuropsychological Tests</topic><topic>Novelty</topic><topic>Parkinson's disease</topic><topic>Parkinsonian Disorders - complications</topic><topic>Parkinsonian Disorders - drug therapy</topic><topic>Parkinsonian Disorders - physiopathology</topic><topic>raphe</topic><topic>Raphe nuclei</topic><topic>Raphe Nuclei - physiopathology</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Serotonin</topic><topic>Serotonin - physiology</topic><topic>Swimming</topic><topic>Thalamus</topic><topic>Thalamus - physiopathology</topic><topic>Therapeutic applications</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sourani, Daphna</creatorcontrib><creatorcontrib>Eitan, Renana</creatorcontrib><creatorcontrib>Gordon, Noam</creatorcontrib><creatorcontrib>Goelman, Gadi</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Neurosciences Abstracts</collection><jtitle>The European journal of neuroscience</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sourani, Daphna</au><au>Eitan, Renana</au><au>Gordon, Noam</au><au>Goelman, Gadi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The habenula couples the dopaminergic and the serotonergic systems: application to depression in Parkinson's disease</atitle><jtitle>The European journal of neuroscience</jtitle><addtitle>Eur J Neurosci</addtitle><date>2012-09</date><risdate>2012</risdate><volume>36</volume><issue>6</issue><spage>2822</spage><epage>2829</epage><pages>2822-2829</pages><issn>0953-816X</issn><eissn>1460-9568</eissn><abstract>A high percentage of patients with Parkinson’s disease suffer from depression in addition to their motor disabilities. However, the etiology of this depression and its relation to Parkinson’s disease are unknown. Within the framework of the monoamine deficiency hypothesis of depression, we propose that the dopaminergic and serotonergic systems are coupled by the lateral habenula, and argue that altered basal ganglia activity leads to lateral habenula hyperactivity, which in turn down‐regulates the serotonergic system, resulting in depressive symptoms in patients with Parkinson’s disease. We tested this hypothesis using the unilateral 6‐hydroxydopamine hemiparkinsonian rat model of Parkinson’s disease. Behavior was assessed using the novelty suppressed feeding and forced swim tests, and the effective connectivity of the serotonergic system was estimated by manganese‐enhanced magnetic resonance imaging of the raphe nuclei. The results show depression‐like behaviors and reduced raphe connectivity with the lateral habenula, dentate gyrus of the hippocampus, thalamus and hypothalamus in the 6‐hydroxydopamine rat groups. More importantly, partial restoration of the raphe connectivity and partial normalization of behavior were achieved by dopamine replacement therapy (apomorphine, 10 mg/kg, s.c. daily). Furthermore, nearly complete behavioral normalization was reached after a bilateral electric lesion of the lateral habenula. These findings provide a plausible link between Parkinson’s disease and depression and open up avenues for new therapeutic interventions in depression and possibly in Parkinson’s disease. A high percentage of patients with Parkinson’s disease suffer from depression in addition to their motor disabilities. However, the etiology of this depression and its relation to Parkinson’s disease are unknown.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>22774942</pmid><doi>10.1111/j.1460-9568.2012.08200.x</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0953-816X
ispartof The European journal of neuroscience, 2012-09, Vol.36 (6), p.2822-2829
issn 0953-816X
1460-9568
language eng
recordid cdi_proquest_miscellaneous_1093447848
source MEDLINE; Wiley Online Library Journals Frontfile Complete
subjects 6-Hydroxydopamine
6-hydroxydopamine rat model
Animal models
Animals
Antiparkinson Agents - pharmacology
Apomorphine - pharmacology
Basal ganglia
Dentate gyrus
Depression
Depression - etiology
Dopamine
Dopamine - physiology
Etiology
Habenula
Habenula - physiopathology
Hippocampus
Hippocampus - physiopathology
lateral habenula
Magnetic Resonance Imaging
Male
manganese-enhanced magnetic resonance imaging
Movement disorders
Neural networks
Neurodegenerative diseases
Neuropsychological Tests
Novelty
Parkinson's disease
Parkinsonian Disorders - complications
Parkinsonian Disorders - drug therapy
Parkinsonian Disorders - physiopathology
raphe
Raphe nuclei
Raphe Nuclei - physiopathology
Rats
Rats, Sprague-Dawley
Serotonin
Serotonin - physiology
Swimming
Thalamus
Thalamus - physiopathology
Therapeutic applications
title The habenula couples the dopaminergic and the serotonergic systems: application to depression in Parkinson's disease
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-13T23%3A49%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20habenula%20couples%20the%20dopaminergic%20and%20the%20serotonergic%20systems:%20application%20to%20depression%20in%20Parkinson's%20disease&rft.jtitle=The%20European%20journal%20of%20neuroscience&rft.au=Sourani,%20Daphna&rft.date=2012-09&rft.volume=36&rft.issue=6&rft.spage=2822&rft.epage=2829&rft.pages=2822-2829&rft.issn=0953-816X&rft.eissn=1460-9568&rft_id=info:doi/10.1111/j.1460-9568.2012.08200.x&rft_dat=%3Cproquest_cross%3E1041143449%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1041143449&rft_id=info:pmid/22774942&rfr_iscdi=true